
PACS Stock Forecast & Price Target
PACS Analyst Ratings
Bulls say
PACS Group is a leading provider of skilled nursing facilities, with a sizable and growing footprint and attractive clinical capabilities. The company has a strong financial outlook, with projected adjusted EBITDA of $555-$575M in 2026. With a decentralized model and focus on underperforming facilities, PACS has the potential for significant growth in the fragmented post-acute care market.
Bears say
PACS Group is facing operational challenges and reporting delays due to an internal investigation, which may impact its ability to gain momentum and execute its M&A strategy in the near term. The company's leverage position is relatively low, but may not be enough to support its M&A strategy if it continues to face hurdles. Despite a robust M&A pipeline, there are uncertainties surrounding the timing and success of potential deals, leading to a negative outlook on the stock.
This aggregate rating is based on analysts' research of PACS Group, Inc. and is not a guaranteed prediction by Public.com or investment advice.
PACS Analyst Forecast & Price Prediction
Start investing in PACS
Order type
Buy in
Order amount
Est. shares
0 shares